Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM P Evans Regulatory News (MPE)

Share Price Information for M P Evans (MPE)

Share Price is delayed by 15 minutes
Get Live Data
1,482.00    -20.00 (-1.33%)
Bid:
1,468.00
Ask:
1,478.00
Spread: 10.00 (0.681%)
Market Cap: £772.28m
MPE Live PriceLast checked at - London Stock Exchange

Intraday M P Evans Share Chart

Acquisition

6 Mar 2023 07:00

RNS Number : 8974R
M. P. Evans Group PLC
06 March 2023
Β 

M.P. EVANS GROUP PLC

("The Group" or "M.P.Evans")

Β 

ACQUISITION OF PLANTED LAND IN INDONESIA

Β 

The board of M.P.Evans, the producer of sustainable palm oil, is pleased to announce, in line with its growth strategy, the acquisition, for cash, of additional planted land, adjacent to the Group's Simpang Kiri estate, in Indonesia.

Β 

The Group has been successful in acquiring 100% of the shares in two Indonesian companies, PT Teunggulon Raya and PT Dharma Agung, which between them own 2,100 hectares planted with oil palm. All the land being acquired is fully titled, with long leaseholds already established with the Indonesian government, in a similar way to the Group's existing properties. The planted land is close to the Group's Simpang Kiri estate in Aceh Province, Northern Sumatra. Total costs associated with the acquisition, including the assumption of liabilities within the companies acquired, are estimated to be US$14.3 million, giving rise to a purchase cost of US$6,800 per hectare. The Group does expect to replant some of the acquired areas in the near term, as part of its plans to bring them up to Group standards.

Β 

Following the acquisition, the Group will have an expanded planted area of 4,800 hectares at or around the Simpang Kiri estate, and the potential to build its own palm-oil mill there. If one is developed, the Group would reach a position of processing 100% of its own crop, as well as further increasing its sustainable palm-oil production.

Β 

Commenting on the acquisition, Peter Hadsley-Chaplin, executive chairman, said:

Β 

"This is an excellent acquisition, fully in keeping with our stated strategy and supported by the strength of the Group's balance sheet. Thanks to a combination of the good price at which it has been secured, and the added scale it gives the Group around Simpang Kiri, these additional hectares are further fuel for the M.P.Evans growth engine."

Β 

6 March 2023

Β 

Enquiries:

M.P. Evans Group PLC

+44 (0)1892 516333

Peter Hadsley-Chaplin

Executive chairman

Matthew Coulson

Chief executive

Luke Shaw

Chief financial officer

Peel Hunt LLP (Nomad and joint broker)

+44 (0)20 7418 8900

Dan Webster, Andrew Clark, Lalit Bose

finnCap (Joint broker)

+44 (0)20 7220 0500

Tim Redfern, Harriet Ward

Hudson Sandler (Financial PR)

+44 (0)20 7796 4133

Charlie Jack, Francis Kerrigan, Amelia Craddock

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
ACQUPUAUWUPWGAW
Date   Source Headline
6th Dec 20197:00 amRNSTransaction in Own Shares
5th Dec 20197:00 amRNSTransaction in Own Shares
4th Dec 20197:00 amRNSTransaction in Own Shares
2nd Dec 20193:41 pmRNSTotal Voting Rights
28th Nov 20197:00 amRNSTransaction in Own Shares
22nd Nov 20197:00 amRNSTransaction in Own Shares
21st Nov 20197:00 amRNSTransaction in Own Shares
20th Nov 20197:00 amRNSTransaction in Own Shares
14th Nov 20197:00 amRNSTransaction in Own Shares
13th Nov 20197:00 amRNSTransaction in Own Shares
8th Nov 201910:42 amRNSTransaction in Own Shares
7th Nov 20197:00 amRNSTransaction in Own Shares
6th Nov 20197:00 amRNSTransaction in Own Shares
5th Nov 20197:00 amRNSTransaction in Own Shares
1st Nov 20194:45 pmRNSTotal Voting Rights
1st Nov 20197:00 amRNSTransaction in Own Shares
31st Oct 20197:00 amRNSTransaction in Own Shares
30th Oct 20197:00 amRNSTransaction in Own Shares
29th Oct 20197:00 amRNSTransaction in Own Shares
25th Oct 20197:00 amRNSTransaction in Own Shares
24th Oct 20197:00 amRNSTransaction in Own Shares
23rd Oct 20197:00 amRNSTransaction in Own Shares
22nd Oct 20197:00 amRNSTransaction in Own Shares
18th Oct 20197:00 amRNSTransaction in Own Shares
17th Oct 20197:00 amRNSTransaction in Own Shares
16th Oct 20197:00 amRNSTransaction in Own Shares
15th Oct 20197:00 amRNSTransaction in Own Shares
11th Oct 20197:00 amRNSTransaction in Own Shares
10th Oct 20197:00 amRNSTransaction in Own Shares
9th Oct 20198:25 amRNSTransaction in Own Shares
8th Oct 20197:00 amRNSTransaction in Own Shares
4th Oct 20197:00 amRNSTransaction in Own Shares
3rd Oct 20197:00 amRNSTransaction in Own Shares
2nd Oct 20197:00 amRNSTransaction in Own Shares
1st Oct 20195:24 pmRNSTotal Voting Rights
27th Sep 20197:00 amRNSTransaction in Own Shares
26th Sep 20197:00 amRNSTransaction in Own Shares
25th Sep 20197:00 amRNSTransaction in Own Shares
24th Sep 20197:00 amRNSTransaction in Own Shares
20th Sep 20197:00 amRNSTransaction in Own Shares
19th Sep 20197:00 amRNSTransaction in Own Shares
18th Sep 20197:00 amRNSTransaction in Own Shares
17th Sep 201910:00 amRNSPosting of Interim Report
17th Sep 20197:00 amRNSTransaction in Own Shares
16th Sep 20199:18 amRNSAcquisition
16th Sep 20197:00 amRNSHalf-year Report
13th Sep 20197:00 amRNSChange of Auditor
11th Sep 20197:00 amRNSTransaction in Own Shares
10th Sep 20197:00 amRNSTransaction in Own Shares
9th Sep 20197:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.